跳至主要内容
临床试验/NCT01176994
NCT01176994Unknown1 期

Safety of Formalin-free Fixatives for In-Vivo Fixation of Skin Lesions.

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2010年12月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
200
试验地点
1
主要终点
Safety

研究概览

简要总结

Existing methods of diagnosing and treating skin lesions are either surgical, which enables an histological diagnosis or destructive (electrodesiccation, liquid nitrogen, laser, caustics) with no possibility of obtaining histology. The ingredients of current formulations for in-vivo skin fixation (Mohs, Solcoderm) are unstable, inconvenient for application and painful - therefore their use was abandoned. The investigators will examine the safety of stable formalin-free formulations for in-vivo fixation of human skin lesions .These formulations were safe and had a rapid onset of fixation effect in in-vivo animal studies.

详细描述

The formulations are comprised of standard non-toxic laboratory chemicals that are used in various dermatological preparations.

Transition metal salts - Zinc chloride, zinc bromide, zinc iodide,zinc nitrate, zinc sulphate. copper chloride ,copper bromide, copper iodide, copper nitrate, copper sulphate.

Keratolytics - salicylic acid , lactic acid, nitric acid, pyruvic acid,oxalic acid, trichloro acetic acid, phenol, resorcinol,urea .

The solvents and penetration enhancers of the ingredients - Water, ethanol, dimethyl sulfoxide, propylene glycol, glycerol.

Patients with skin lesions that after clinical diagnosis are usually treated by dermatologists with destructive modalities without an histological evaluation will be included in the study. The clinical diagnoses include viral warts, seborrheic warts, skin tags, solar keratoses, fibromata and hemangiomata.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Patients with skin lesions that are not treated with histology

排除标准

  • •Seriously ill patients

研究组 & 干预措施

Skin lesions

Experimental

Individuals with skin lesions whose lesions are not sent for histology by dermatologists

干预措施: Formulations for in-vivo fixation (Device)

结局指标

主要结局

Safety

时间窗: One year

Infiltration of formulations into skin lesions.

Safety of formulations

时间窗: One year

Infiltration of the formulations into skin lesions with resultant in-vivo fixation and the achievement of histological result. Possible local pain, infection and scarring will be evaluated.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验

已完成
不适用
The biological dressing and conventional treatment in patients with massive burn: a clinical trialBurnsInjury, Occupational Diseases, Poisoning
ISRCTN01055688Zanjan University of Medical Sciences (Iran)118
进行中(未招募)
不适用
The feasibility and efficacy of subcutaneous and intravenous Plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: a randomized phase II study. - HOVON 107 MOBILIZATIOstem cell mobilizationMedDRA version: 12.1Level: LLTClassification code 10053948Term: Hematopoietic stem cell mobilizationMedDRA version: 12.1Level: LLTClassification code 10024329Term: LeukemiaMedDRA version: 12.1Level: LLTClassification code 10028533Term: Myelodysplastic syndrome
EUCTR2010-023436-16-NLHOVON Foundation
已完成
不适用
Treatment of chronic wounds using FN coating wound bed combined with autologous skin cell suspension and Split-thickness skin grafting: A randomized controlled trialTreatment of chronic wounds is a big clinically challenging based on low graft take rates associated with current surgery, and the cell utilization and therapeutic effects for chronic wounds need to be improved.
JPRN-UMIN000032618The First Affiliated Hospital of Sun Yat-sen University Department of Burn Surgery102
暂停
不适用
Confocal Microscopy of Benign and Malignant Skin TumorsSkin Cancer
NCT01010321Sheba Medical Center60
已完成
不适用
Autologous Fibrin Glue for Dermal Ulcer TreatmentDermal UlcerRefractoryD012883
JPRN-jRCTs052190052Kawamoto Shinichiro2